A recent study conducted at UKE Hamburg compared manual and software-assisted assessments of computed tomography (CT) scans according to iRECIST (immune Response Evaluation Criteria in Solid Tumors) in oncological patients undergoing immune-based treatment. Utilizing mint Lesion™ for software-assisted assessment, the study found that software-assisted assessments resulted in shorter reading times, lower error rates, and higher inter-reader agreement compared to manual assessments. The researchers thus concluded that software-assisted iRECIST assessments are preferable over manual approaches for optimal oncological response evaluation.
Software-Assisted CT Assessment Outperforms Manual Methods in Oncology Study
Related Resources
Related Resources
New iRECIST whitepaper published
We are happy to present our newly published whitepaper on iRECIST and its application. This is available here on our homepage as well as on www.irecis…
University Hospital Ulm: Pilot study shows discriminatory power of MRI-based 3d texture analysis for bone lesions
Distinguishing between enchondroma, a benign tumor, and low-grade chondrosarcoma, which is a low-aggressivity malignancy, is a frequent challenge, as…
4 Questions – 4 Answers // Imaging in Clinical Trials
Mint Medical, Inc. Vice President of Clinical Trials, Kelie Luby Discusses Advances in Imaging Analysis in Clinical Trials and What’s Next for Mint…